Profound Research LLC at Southern California Heart Specialists | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation	Arrhythmias, Cardiac, Embolism and Thrombosis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, thrombotic disease, vascular disorder	Recruiting	Phase 2	2026-10-09		NCT07175428
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis	Transthyretin Amyloid Cardiomyopathy (ATTR CM)	Recruiting	Phase 3	2026-09-22		NCT07207811
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable	Arrhythmias, Cardiac, Embolism, Embolism and Thrombosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic stroke, lung disorder, nervous system disorder, pulmonary embolism, respiratory system disorder, stroke disorder, thrombotic disease, vascular disorder, venous thromboembolism	Recruiting	Phase 3	2026-09-17		NCT07430956
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study	Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder	Recruiting	Phase 2 / Phase 3	2026-07-06		NCT07001800